Phase I study with pemetrexed, cisplatin and concurrent radiotherapy in limited-stage small cell lung cancer (LS-SCLC)

V. Surmont, K. Nackaerts, S. Senan, C.J. Kraaij, N. Chouaki, RJ van Klaveren, J Vansteenkiste, E.F. Smit

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	541-541
Journal	European Journal of Cancer. Supplement
Volume	7
Issue number	2
DOIs	https://doi.org/10.1016/s1359-6349(09)71835-x
Publication status	Published - 2009

Cite this

@article{850b70b9cf8c4998a4a155a01ffa3a4e,

title = "Phase I study with pemetrexed, cisplatin and concurrent radiotherapy in limited-stage small cell lung cancer (LS-SCLC)",

author = "V. Surmont and K. Nackaerts and S. Senan and C.J. Kraaij and N. Chouaki and {van Klaveren}, RJ and J Vansteenkiste and E.F. Smit",

year = "2009",

doi = "10.1016/s1359-6349(09)71835-x",

language = "Undefined/Unknown",

volume = "7",

pages = "541--541",

journal = "European Journal of Cancer. Supplement",

issn = "1359-6349",

publisher = "Elsevier Limited",

number = "2",

}

In: European Journal of Cancer. Supplement, Vol. 7, No. 2, 2009, p. 541-541.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Phase I study with pemetrexed, cisplatin and concurrent radiotherapy in limited-stage small cell lung cancer (LS-SCLC)

AU - Surmont, V.

AU - Nackaerts, K.

AU - Senan, S.

AU - Kraaij, C.J.

AU - Chouaki, N.

AU - van Klaveren, RJ

AU - Vansteenkiste, J

AU - Smit, E.F.

PY - 2009

Y1 - 2009

U2 - 10.1016/s1359-6349(09)71835-x

DO - 10.1016/s1359-6349(09)71835-x

M3 - Article

VL - 7

SP - 541

EP - 541

JO - European Journal of Cancer. Supplement

JF - European Journal of Cancer. Supplement

SN - 1359-6349

IS - 2

ER -